//]]>

Extravasation of Cytotoxic Agents (Record no. 20183)

000 -LEADER
fixed length control field 03912nam a22005415i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150653.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100301s2010 au | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783211888933
978-3-211-88893-3
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC254-282
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994
Edition number 23
264 #1 -
-- Vienna :
-- Springer Vienna :
-- Imprint: Springer,
-- 2010.
912 ## -
-- ZDB-2-SME
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mader, Ines.
Relator term author.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Extravasation of Cytotoxic Agents
Medium [electronic resource] :
Remainder of title Compendium for Prevention and Management /
Statement of responsibility, etc by Ines Mader, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer.
250 ## - EDITION STATEMENT
Edition statement 2.
300 ## - PHYSICAL DESCRIPTION
Extent XIII, 394 p.
Other physical details online resource.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Problem outline -- Problem outline -- General part -- and definitions -- Predisposition and prevention -- Clinical practice -- Measures -- Aftercare -- Documentation -- Forming clinical working groups -- Quality control and quality assurance -- Open questions and outlook -- Substance-specific part -- Remarks on the substance-specific part -- Amsacrine -- L-Asparaginase -- Bendamustine -- Bleomycin -- Bortezomib -- Busulfan -- Carboplatin -- Carmustine -- Cisplatin -- Cladribine -- Cyclophosphamide -- Cytarabine -- Dacarbazine -- Dactinomycin -- Daunorubicin -- Daunorubicin liposomal -- Docetaxel -- Doxorubicin -- Doxorubicin liposomal, Doxorubicin pegylated liposomal -- Epirubicin -- Estramustine -- Etoposide -- Etoposide phosphate -- Fludarabine -- 5-Fluorouracil -- Fotemustine -- Gemcitabine -- Idarubicin -- Ifosfamide -- Irinotecan -- Melphalan -- Methotrexate -- Mitomycin C -- Mitoxantrone -- Nimustine -- Oxaliplatin -- Paclitaxel -- Pegaspargase -- Pemetrexed -- Pentostatin -- Raltitrexed -- Streptozocin -- Teniposide -- Thiotepa -- Topotecan -- Treosulfan -- Trimetrexate -- Vinblastine -- Vincristine -- Vindesine -- Vinorelbine.
520 ## - SUMMARY, ETC.
Summary, etc The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm, general measures in handling extravasated drugs, specific antidotes, and documentation. In the 2nd edition, the scientific information contained in the general section and relating to the actual substances has been updated. The substance specific part of the book includes detailed instructions on handling more than 50 cytotoxic drugs, to initiate targeted measures. Templates for an extravasation set, overview tables, documentation sheets, and patient information, as we as a CD-ROM are included to support clinical practice. The book is the outcome of a consensus of an interdisciplinary working group that has collected and systematically reviewed all published literature on the topic.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Toxicology.
Topical term or geographic name as entry element Internal medicine.
Topical term or geographic name as entry element Hematology.
Topical term or geographic name as entry element Nursing.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Medicine & Public Health.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Hematology.
Topical term or geographic name as entry element Nursing.
Topical term or geographic name as entry element Pharmacology/Toxicology.
Topical term or geographic name as entry element Internal Medicine.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fürst-Weger, Patrizia.
Relator term author.
Personal name Mader, Robert.
Relator term author.
Personal name Nogler-Semenitz, Elisabeth.
Relator term author.
Personal name Wassertheurer, Sabine.
Relator term author.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9783211888896
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-3-211-88893-3
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-07AUM Main Library2014-04-07 2014-04-07 E-Book   AUM Main Library616.994

Languages: 
English |
العربية